I have reason to believe the research is riskier than it needs to be in some cases, based on experience with some similar issues.   In some cases, more fundamental metabolic issues may be overlooked, and that may not be factored properly into the viability assessment before preliminary research proceeds.   This is definitely not an area I would advise anyone to invest but those with a good grasp of the science involved.